Premarket Biotech Digest – CELG Inks New Deal, LLY Gets Favorable Ruling, ALR Modifies Deal
July 10, 2017 at 11:21 AM EDT
Celgene Corporation announced that it has agreed to acquire a stake in BeiGene. The deal has valued BeiGene stock at $4.58 apiece.